logo
Select company
Select metric
$ 463.81MCore Assets
VS
Market
45
Sector
77
Industry
87
History
94
$ 7.41Close
$ 5.8 - $ 16.39 52-Week Range
Ticker Information

Ticker

DAWN

Company Name

DAY ONE BIOPHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DAY ONE BIOPHARMACEUTICALS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DAWN - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 519.04M$ 35.62M$ 463.81M$ 19.61M
3/31/2025$ 534.36M$ 33.36M$ 480.59M$ 20.41M
12/31/2024$ 582.79M$ 124.97M$ 442.19M$ 15.63M
9/30/2024$ 600.81M$ 422.76M$ 161.83M$ 16.22M
6/30/2024$ 400.44M$ 239.62M$ 144.02M$ 16.8M
3/31/2024$ 326.64M$ 270.39M$ 56.25M$ 0
12/31/2023$ 376.05M$ 230.78M$ 145.26M$ 0
9/30/2023$ 414.18M$ 241.18M$ 173M$ 0
6/30/2023$ 450.76M$ 189.21M$ 261.55M$ 0
3/31/2023$ 323.56M$ 49.27M$ 274.3M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DAY ONE BIOPHARMACEUTICALS INC's latest trailing twelve months (TTM) Core Assets stands at $ 1.93M.
  • Over the past 5 years, DAY ONE BIOPHARMACEUTICALS INC's average Core Assets has been $ 167.07M.
  • The median Core Assets for DAY ONE BIOPHARMACEUTICALS INC during this period was $ 145.26M
  • DAY ONE BIOPHARMACEUTICALS INC reached its highest Core Assets over the past 5 years at $ 480.59M.
  • The lowest Core Assets recorded by DAY ONE BIOPHARMACEUTICALS INC in the same timeframe $ 1.93M

DAY ONE BIOPHARMACEUTICALS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
STOK : STOKE THERAPEUTICS INC $ 282.96MAKBA : AKEBIA THERAPEUTICS INC $ 149.24MDNA : GINKGO BIOWORKS HOLDINGS INC $ 961.29MGERN : GERON CORP $ 475.59MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 304.56MKROS : KEROS THERAPEUTICS INC $ 65.5MNAGE : NIAGEN BIOSCIENCE INC $ 30.77MPHAT : PHATHOM PHARMACEUTICALS INC $ 97.79MANAB : ANAPTYSBIO INC $ 290.95MXNCR : XENCOR INC $ 823.44M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for DAY ONE BIOPHARMACEUTICALS INC is calculated as follows: Assets [ $ 45.66M ] - Intangibles [ $ 0 ] - CashnEq [ $ 43.73M ]
(=) Core Assets [ $ 1.93M ]

DAWN - Core Assets, Last 5 years

$ 1.93M

Minimum

Dec 31, 2020

$ 480.59M

Maximum

Mar 31, 2025

$ 167.07M

Average

$ 145.26M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.38M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.36B
average$ 798.38M
median$ 287.61M
std$ 1.05B